Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001562180-19-005642

Director bought 5,800 shares at $3.43 ($19,894)

From the SEC's structured data for this filing

Trades in this filing

GILMAN STEVEN C · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-11-20 Purchase : show line 1 in the form +5,800 $3.43 $19,894 29,731 D
Open-market purchases · 5,800 sh · avg $3.43 · $19,894
Loading xslF345X03/primarydocument.xml…